Ablative Solutions Announces Enrollment and Randomization of First Patient in Global Clinical Trial Evaluating Company's Novel Therapy for Uncontrolled Hypertension
Advertisement
TARGET BP Clinical Program studies renal denervation using the investigational Peregrine System Kit